Federal and Regulatory Outreach
AMRPA Letter of Support for Prior Authorization Reform Bill H.R. 3173
May 14, 2021
Legislative Medicare Advantage Prior Authorization
PAC Groups Joint Letter of Support for TRIA 2021
April 27, 2021
IMPACT Act Legislative
AMRPA Letter of Support for The Resetting the IMPACT Act (TRIA) of 2021
April 15, 2021
IMPACT Act Legislative
AMRPA & NALTH Send Joint Response to CMS on Medicare Advantage Prior Authorization Issues during the Public Health Emergency
March 18, 2021
Medicare Advantage Prior Authorization Regulatory
AMRPA’s Comment Letter on the CMS Proposed IRF Review Choice Demonstration
February 17, 2021
Regulatory Review Choice Demonstration
AMRPA Second Round Comment Letter to NQF on IRF Measure Under Consideration
January 19, 2021
COVID-19 Quality Regulatory
AMRPA Comment Letter to NQF on IRF Measure Under Consideration
January 6, 2021
COVID-19 Quality Regulatory
AMRPA Responds to MedPAC December 2020 Session on IRF Payment Adequacy and Access
December 29, 2020
Medicare Advantage MedPAC Regulatory
AMRPA Submits Comments on HHS RFI on COVID-19 Regulatory Changes
December 28, 2020
Burden Reduction COVID-19 Prior Authorization Regulatory Telehealth
AMRPA Submits Policy Priorities & Recommendations to Biden-Harris Transition Team
December 18, 2020
COVID-19 IMPACT Act Legislative Medicare Advantage Price Transparency Prior Authorization Telehealth
AMRPA Comments to CMS/RTI Regarding Unified PAC PPS Prototype Work
December 17, 2020
IMPACT Act Regulatory Unified PAC Payment
AMRPA Submits Comments to CMS: re FY 2022 IRF PPS Proposed Rule